Akanda Corp. (AKAN)
NASDAQ: AKAN · IEX Real-Time Price · USD
2.230
-0.030 (-1.33%)
At close: Jul 2, 2024, 4:00 PM
2.290
+0.060 (2.69%)
After-hours: Jul 2, 2024, 6:34 PM EDT
Akanda Market Cap
Akanda has a market cap or net worth of $4.27 million as of July 2, 2024. Its market cap has increased by 64.39% in one year.
Market Cap
4.27M
Enterprise Value
8.18M
1-Year Change
64.39%
Ranking
Category
Stock Price
$2.23
Market Cap Chart
Since the IPO on March 15, 2022, Akanda's market cap has decreased from $115.61M to $4.27M, a decrease of -96.30%. That is a compound annual growth rate of -76.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 500.00K | -72.22% |
| Dec 29, 2023 | 1.80M | -58.14% |
| Dec 30, 2022 | 4.30M | -96.28% |
| Mar 15, 2022 | 115.61M | - |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biofrontera | 4.54M |
| Enveric Biosciences | 4.52M |
| Sonoma Pharmaceuticals | 4.37M |
| MyMD Pharmaceuticals | 4.36M |
| Artelo Biosciences | 4.36M |
| Predictive Oncology | 4.23M |
| Theriva Biologics | 4.17M |
| CERo Therapeutics Holdings | 4.14M |